Catalyst
Slingshot members are tracking this event:
Actinium (ATNM) Initiates Phase 2 Trial Evaluating Actimab-A in Newly Diagnosed Acute Myeloid Leukemia Patients Over Age 60
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATNM |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trial Initiation, Phase 2, Actimab-a, Newly Diagnosed Acute Myeloid Leukemia, Age 60
